Note 9 - Shareholders' Equity

3 Months Ended

May 27, 2018

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

9

.

SHAREHOLDERS

’

EQUITY

During the

13

weeks ended

May 27, 2018,

the Company sold

2,987

shares of the Company’s treasury stock pursuant to the exercises of employee stock options and received proceeds of

$47

from such exercises and recognized stock-based compensation expense, net of recognized tax benefits, of

$201.

These transactions resulted in a

$187

increase in additional paid-in capital during the period.

On

January 8, 2015,

the Company announced that its Board of Directors authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,250,000

shares of its common stock, representing approximately

6%

of the Company’s

20,945,634

total outstanding shares as of the close of business on

January 7, 2015.

This authorization superseded all prior Board of Directors’ authorizations to purchase shares of the Company’s common stock.

On

March 10, 2016,

the Company announced that its Board of Directors authorized the Company’s purchase, on the open market and in privately negotiated transactions, of up to

1,000,000

additional shares of its common stock, in addition to the unused prior authorization to purchase shares of the Company’s common stock announced on

January 8, 2015.

As a result, the Company is authorized to purchase up to a total of

1,531,412

shares of its common stock, representing approximately

7.6%

of the Company’s

20,244,558

total outstanding shares as of the close of business on

June 27, 2018.

The Company did

not

purchase any shares of its common stock during the

13

weeks ended

May 27, 2018

or during the

13

weeks ended

May 28, 2017.